Alabama Awards $280,806 for Drug Treatment in Eight State Prisons

Alabama will spread $280,806 across eight state prisons to run a 12-month residential substance abuse treatment program, using federal Justice Department money that the Alabama Department of Economic and Community Affairs administers. Gov. Kay Ivey's office announced the award on Oct. 15. The Department of Corrections is contributing $93,602 in matching funds.

The facilities named in the release are Bibb, Bullock, William E. Donaldson, Easterling, Staton, Ventress and St. Clair correctional facilities, plus Julia Tutwiler Prison for Women. Each will host the same program model: drug treatment staff providing education and counseling, with drug testing scheduled before entry, during the program and after a participant completes it, for as long as that person remains in ADOC custody.

Ivey framed the spending as a recidivism measure rather than a health one. "Ending drug addictions reduces recidivism and puts inmates on a path toward a more productive life upon release," she said in the announcement. "This grant will ensure state prisons get the tools they need to help participants in the program overcome the destructive influence of illegal drug use."

A testing schedule that does not stop at graduation

The detail that distinguishes this program from a classroom-based course is the testing regimen. Participants are screened before they enter, while they are in treatment and after they finish, with the state continuing to test for as long as the person stays in the system. In practice that means a prisoner who completes the program and returns to a general population unit remains subject to drug screening tied to the treatment record.

ADECA Director Kenneth Boswell described the timing of the intervention as the point of the grant. "Treating addiction before prisoners are reintegrated into the community is crucial, because drug abuse is so closely linked with crime," he said. "ADECA joins Gov. Ivey in support of this program and its focus on lasting recovery."

A formula grant routed through Montgomery

The money originates in the federal Residential Substance Abuse Treatment for State Prisoners program, known as RSAT, which the Bureau of Justice Assistance distributes to states as a formula grant rather than through a competitive application. States route the funds through an administering agency — in Alabama, ADECA — which then contracts with the corrections department.

That structure also explains the scale. Alabama's own contribution is roughly a third of the federal total, and a formula allocation divided across eight facilities works out to about $35,000 per prison — enough for staff time, curriculum materials and testing supplies, not enough to build new treatment units.

Residential programs inside correctional facilities differ from residential treatment in the community in one important respect: the setting is a prison, and participation is arranged around a sentence rather than around a clinical placement decision. The clinical content — education, counseling, structured days — overlaps; the voluntariness and the discharge plan do not.

What the announcement leaves out

The release does not say how many prisoners each facility will enroll, how many treatment staff members will be assigned, which curriculum the counselors will use, or what outcome the state will measure beyond continued drug testing. It sets no target for post-release abstinence or re-arrest, and it does not describe how a participant's treatment record travels with them to a community provider at release.

Those omissions matter for judging the program's reach. A 12-month residential program with a fixed staff complement can serve only a fraction of the people inside a facility at any given time, and Alabama's prison population is large relative to the number of beds any single grant of this size can support. The state did not publish a capacity figure.

Inside treatment and the handoff at the gate

The practical question for corrections-based addiction treatment is what happens in the first weeks after release, when tolerance has dropped, the supply is unchanged and the structure of a prison treatment unit disappears. Programs that stop at the gate leave that gap to community providers, and the handoff is not always documented.

For people leaving custody with an opioid use disorder, the medications approved to treat it — methadone, buprenorphine and naltrexone — are the interventions with the strongest evidence behind them, and beginning one before release removes the gap between the last dose inside and the first appointment outside. The Alabama grant funds counseling and testing, not medication, and the release does not describe a linkage agreement with any community prescriber.

ADECA administers a range of state and federal programs beyond substance abuse, including law enforcement, victim services and economic development grants. The prison treatment award was one of several the office announced in October.